Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis

被引:18
|
作者
Salajegheh, Mohammad
Raju, Raghavan
Schmidt, Jens
Dalakas, Marinos C.
机构
[1] Brigham & Womens Hosp, Div Neuromusc Dis, Dept Neurol, Boston, MA 02115 USA
[2] Ctr Surg Res, Dept Surg, Birmingham, AL 35294 USA
[3] Univ Gottingen, Inst Expt & Clin, Muscle Immunobiol Sect, D-37073 Gottingen, Germany
[4] NINDS, Neuromusc Dis Sect, NIH, Bethesda, MD 20892 USA
关键词
inclusion body myositis; dermatomyositis; thrombospondin; CD47; CD36; amyloid;
D O I
10.1016/j.jneuroim.2007.04.022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The TSPI/CD36/CD47-complex is involved in T cell expansion and inflammatory responses to beta-amyloid, both relevant to IBM. We report on the mRNA and protein expression of TSP1/CD36/CD47-complex in IBM muscles and in human myoblasts after cytokine stimulation. The TSP1/CD36/CD47 was upregulated in IBM. TSPI immunolocalized to the connective tissue contiguous to inflammation and CD36/CD47 on the myofibers and CD8+ cells. Further, TNF-alpha upregulated the production of TSP1 and CD47 by myoblasts. The TSP-complex is another inflammatory mediator associated with chronic inflammation in IBM that may perpetuate the immune responses to local antigens in response to TNF-alpha. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:166 / 174
页数:9
相关论文
共 50 条
  • [1] Thrombospondin-1 (TSP1) and its binding partners CD36 and CD47, as mediators of inflammation in sporadic inclusion body myositis (sIBM)
    Salajegheh, M
    Raju, R
    Schmidt, J
    Dalakas, MC
    NEUROLOGY, 2005, 64 (06) : A158 - A158
  • [2] Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
    Tanase, Cristiana
    Enciu, Ana Maria
    Codrici, Elena
    Popescu, Ionela Daniela
    Dudau, Maria
    Dobri, Ana Maria
    Pop, Sevinci
    Mihai, Simona
    Gheorghisan-Galateanu, Ancuta-Augustina
    Hinescu, Mihail Eugen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [3] Thrombospondin-1 (TSP-1) inhibits endothelial nitric oxide synthase (eNOS) expression in EC through TSP-1/CD36 binding
    Zhao, XM
    Hu, YY
    Mitchell, RN
    Liao, JK
    Libby, P
    CIRCULATION, 2000, 102 (18) : 16 - 16
  • [4] Opposite effects of thrombospondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cells
    Yamauchi, Y
    Kuroki, M
    Imakiire, T
    Uno, K
    Abe, H
    Beppu, R
    Yamashita, Y
    Kuroki, M
    Shirakusa, T
    MATRIX BIOLOGY, 2002, 21 (05) : 441 - 448
  • [5] Thrombospondin-1 (TSP-1) inhibits human megakaryocyte growth in culture and the relation with CD36 expression.
    Li, K
    Yang, M
    Chan, PK
    Yuen, PMP
    Chong, BH
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 770 - 770
  • [6] Characterizing the CD47/TSP-1 Signaling Axis
    Young, Sarah
    Chung, Su
    Montfort, William
    PROTEIN SCIENCE, 2018, 27 : 137 - 137
  • [7] Thrombospondin-1 Binding to CD47 in the Regulation of Nitric Oxide Signaling
    Young, Sarah
    Green, Toni
    Ramanathan, Saumya
    Gage, Matthew
    Montfort, William
    PROTEIN SCIENCE, 2012, 21 : 211 - 211
  • [8] Dysregulated expression of TSP-1 and its receptor CD47 in psoriasis
    De La Fuente, H.
    Velasco, M. L.
    Cibrian, D.
    Madrid, F. S.
    Dauden, E.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 30 - 30
  • [9] CD36 mediates binding of soluble thrombospondin-1 but not cell adhesion and haptotaxis on immobilized thrombospondin-1
    Magnetto, S
    Bruno-Bossio, G
    Voland, C
    Lecerf, J
    Lawler, J
    Delmas, P
    Silverstein, R
    Clezardin, P
    CELL BIOCHEMISTRY AND FUNCTION, 1998, 16 (03) : 211 - 221
  • [10] Molecular mechanisms of TSP-1 internalization by CD36
    Frieda, S
    Pearce, A
    Silverstein, RL
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 3453 - 3453